All listings for this product
Best-selling in Manuals & Resources
Save on Manuals & Resources
- £19.59Trending at £26.34
- £11.28Trending at £14.02
- £9.36Trending at £12.99
- £9.60Trending at £11.18
- £13.65Trending at £14.12
- £12.17Trending at £13.87
- £5.28Trending at £5.79
About this product
- DescriptionThis book surveys current advances in understanding the mechanisms of cancer cell resistance to apoptotic stimuli, which eventually result in cancer progression and metastasis. Developments presented here may help improve clinical response to resistant tumors.
- Author BiographyDr. Benjamin Bonavida is a professor at UCLA's David Geffen School of Medicine for the Department of Microbiology, Immunology, & Molecular Genetics. His other appointments include being a member of the Department of Defense Congressionally Directed Medical Research Program, Member of the National Cancer Institute's SPORE Program, member of the International Scientific Advisory Board of the Israel Cancer Research Foundation, to name a few. He's currently a scientific reviewer for several journals and a member of editorial boards including Journal of Clinical Immunology, International Journal of Oncology, and Cancer Biotherapy & Radiopharmaceuticals. In his career, he's published over 450 papers and reviews, and he's also edited two books with Springer in the past. For more information, please see the CV attached herewith.
- PublisherSpringer-Verlag New York Inc.
- Date of Publication27/04/2013
- GenreClinical Medicine: Professional
- Series TitleResistance to Targeted Anti-Cancer Therapeutics
- Series Part/Volume Number1
- Place of PublicationNew York, NY
- Country of PublicationUnited States
- ImprintSpringer-Verlag New York Inc.
- Content Notebiography
- Weight578 g
- Width155 mm
- Height235 mm
- Spine20 mm
- Edited byBenjamin Bonavida
This item doesn't belong on this page.
Thanks, we'll look into this.